All In Biotech

Free tool

FAERS Monitor: Children'S Allegra Hives

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021909 or its brand name (Children'S Allegra Hives, Fexofenadine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

6,454

Serious

4,307

67% of reports

Hospitalization

2,016

Death reported

426

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective485
  • nausea352
  • diarrhoea350
  • headache348
  • pruritus328
  • fatigue323
  • dizziness290
  • dyspnoea283
  • rash283
  • off label use224
  • pyrexia222
  • pain221
  • pneumonia209
  • malaise207
  • cough198

Reports by year received

View as table
YearReports
2004148
2005140
200629
200731
200837
200948
201020
201136
2012113
2013146
2014148
2015145
2016200
2017250
2018319
2019404
2020493
2021515
2022464
2023586
2024650
2025823
2026709

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,705 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pruritusSignal3282.82.5380
coughSignal1982.32.0146
rashSignal2832.11.9169
pneumoniaSignal2092.11.8122
pyrexiaSignal2222.11.8127
dizziness2901.91.7125
headache3481.81.6129
diarrhoea3501.81.6119
dyspnoea2831.61.570
malaise2071.51.339
nausea3521.41.351
fatigue3231.41.230
drug ineffective4851.21.117
pain2211.21.06
off label use2240.80.78

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.